Member Info for Scinv_temp

The funny part is that I'm mostly fighting the pseudocertainties many people here tend to have by describing some variables. So not only you haven't actually specified the "often wrong" but also you are completely off with "never in doubt", which is the opposite of what I've been saying. Basically, you are saying random things that make no sense in this context, as usual :)

I'd be glad to hear what I was wrong about.

Loooool to the randomness but also that you chose Kafka in particular as an example. Soooo hard lol

I can easily believe you find more substance in sandwiches, to find substance one needs to comprehend first.

One the other hand you make one post and you manage to make it completely void of substance. Each to their own I guess.

I am polite. As much as possible. By the way, don't you have any mirrors where you live? Seriously, you are going to talk to me about politeness?

I'm only trying to help, he was certainly one of the leaders in the sng £50 crowd and the science here so it is certainly weird he chose to hide behind a private club while apparently remaining invested instead of talking about the developments in the science and business here like he did in the past. By his own admission he left because of the "derampers" so I'm just trying to make it easy for him.

I promise not to make a single comment for a week if he starts posting here again properly no matter what the discussions are. So no excuse pmjh :)

The chances are not obviously minuscule

Who would have thought that quickly searching things on the Internet to try and sound knowledgeable would end up in ridicule?

Shocking!!!
Lol

What you wrote, is a different think, and has to do more with patient stratification actually (though not exactly that either) which sng is still trying to figure out

Hahaha hahaha pharmacovigilance perhaps? But this is for already approved drugs. Of course they need to show as well that the drug actually works in the first place.

Saying that those protease inhibitors would favour other infection is misinformation and it does matter actually, just not in the way you think

I obviously meant to write "have NO expertise in"

*£50 pt

I am not the one pretending to understand patterns on a chart, asking people, and insisting no less, for their opinion on something they have already stated they have expertise in is a bad habit that you need to stop for your own good. I did say in the past that the £50 put was delusional but that was based on making the right assumptions on the competitive position of the drug itself rather than whatever voodoo patterns. I also said that I would be happy to exit around £3, but that just means what I would be happy with and obviously if one day it opens above that then I will sell at whatever price it is. I also said that prior to covid this was a 10p stock, which is simply a fact and I added that since then we know the copd results weren't great so if all covid trials fail then I guess it will depend on how much cash they have left to do further trials, so it could be in that case (all covid trials failed and little cash left) under 10p or something that reflects more on their cash position. But this is as much as I would dare to say about price targets.

Sure sure :)

No, what I do understand is drug development and this what I comment on.
So perhaps ask tt that seems to be the expert :)

Yes, but why does your opinion matter? You want from reading patterns on a chart to market analysis, ADRs, manxplaining mechanism of action of drugs you know nothing about, pr strategy etc

By the way, that thing that you heard somewhere about favouring other bacteria or viruses is about immunosuppressive drugs like corticosteroids, not these protease inhibitors and the early treatment is true of all anti virals that are meant to act as antivirals.

Who do you think the government buys it from? And in any case, you need to understand that it is actually available.